2023
The first nicotine product tried is associated with current multiple nicotine product use and nicotine dependence among a nationally representative sample of U.S. youths
Simon P, Buta E, Jackson A, Camenga D, Kong G, Morean M, Bold K, Davis D, Krishnan-Sarin S, Gueorguieva R. The first nicotine product tried is associated with current multiple nicotine product use and nicotine dependence among a nationally representative sample of U.S. youths. Preventive Medicine 2023, 169: 107437. PMID: 36731754, PMCID: PMC10507373, DOI: 10.1016/j.ypmed.2023.107437.Peer-Reviewed Original ResearchConceptsNicotine product useSymptoms of dependenceNicotine dependenceMultiple product useSmokeless tobaccoNicotine productsProduct useSeparate multinomial logistic regression modelsHealth Study Waves 1Wave 1Smokeless tobacco usersHigher nicotine dependence scoresNicotine dependence scoresDemographic factorsLogistic regression modelsMultinomial logistic regression modelsMultivariable modelTobacco usersHigh riskDependence scoresSymptomsGreater likelihoodUse statusWave 4Regression models
2022
Cannabis use among youth who vape nicotine E-cigarettes: A qualitative analysis
Davis DR, Bold KW, Kong G, Cavallo DA, Jackson A, Krishnan-Sarin S. Cannabis use among youth who vape nicotine E-cigarettes: A qualitative analysis. Drug And Alcohol Dependence 2022, 234: 109413. PMID: 35339972, PMCID: PMC9018562, DOI: 10.1016/j.drugalcdep.2022.109413.Peer-Reviewed Original ResearchConceptsE-cigarette useE-cigarettesCannabis useHealth concernPsychoactive effectsStrong psychoactive effectsNicotine e-cigarettesFocus groupsPast-month e-cigarette usePatterns of cannabisCessation programmingSecondary data analysisNicotine productsStudy aimCannabisNicotineNicotine vapingGroupReportDual use
2020
Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies
Jackson A, Grobman B, Krishnan-Sarin S. Recent findings in the pharmacology of inhaled nicotine: Preclinical and clinical in vivo studies. Neuropharmacology 2020, 176: 108218. PMID: 32592708, PMCID: PMC7529934, DOI: 10.1016/j.neuropharm.2020.108218.Peer-Reviewed Original ResearchConceptsE-cigarettesVivo studiesNicotine productsCentral nervous system implicationsNon-combustible nicotine productsNicotine e-cigarettesLung injury casesPharmacokinetics of nicotineE-liquidsHeated tobacco productsTobacco product usersSearch engines PubMedProduct use-associated lung injury (EVALI) casesPharmacodynamic impactNon-combustible productsNicotine inhalerNicotine studiesMouse modelRodent modelsNicotine pharmacologyRodent studiesInjury casesPG/VGPharmacological impactNarrative review